Skip to content
OpenCapital
Get started

Forte Biosciences FBRX Q3 2025 earnings

Reported November 14, 2025 · Before market open

EPS-$0.99Beat by $0.05
EPS estimate-$1.04

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.92

Versus estimates

Diluted EPS

Q1 2026-$1.24Miss by $0.08Q4 2025-$1.45Miss by $0.03
Q3 2025-$0.99Beat by $0.05
Q2 2025-$0.96Beat by $0.25Q1 2025-$1.37Miss by $0.48Q4 2024-$2.45Beat by $2.10

Ask the moment Forte Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Forte Biosciences report Q3 2025 earnings?
Forte Biosciences (FBRX) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Forte Biosciences's Q3 2025 revenue and EPS?
Forte Biosciences reported eps of $-0.99 for Q3 2025.
Did Forte Biosciences beat estimates in Q3 2025?
EPS beat the consensus estimate of $-1.04 by $0.05.
How did Forte Biosciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 78.2% from $-4.54.
Where can I find Forte Biosciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-281807) and the 10-Q periodic report (0001193125-25-281808) directly on SEC EDGAR. The filing index links above go to sec.gov.